Medically managing canine hip dysplasia

Veterinary Medicine

Volumn 91, Issue 1, 1996, Pages 48-53

  Tomlinson, James ^a   McLaughlin Jr , Ron ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040432319     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Barr, A.R.S. et al: Clinical Hip Dysplasia in Growing Dogs: The Long-term Results of Conservative Management. J. Small Anim. Pract. 28:243-252; 1987.
2. Pettipher, E.R.: Pathogenesis and Treatment of Chronic Arthritis. Sci. Prog. 73:521-534; 1989.
3. Clark, D.M.: The Biochemistry of Degenerative Joint Disease and Its Treatment. Compend. Cont. Ed. 13(2):275-284; 1991.
4. Johnston, S.A.: Conservative and Medical Management of Hip Dysplasia. Vet. Clin. North Am. 22(3):595-606; 1992.
5. Riser, W.H.: The Dog as a Model for the Study of Hip Dysplasia. Growth, Form, and Development of the Normal and Dysplastic Hip Joint. Vet. Pathol. 12:234-334; 1975.
6. Riser, W.H.: A Half Century of Canine Hip Dysplasia. Semin. Vet. Med. Surg. (Small Anim.) 2:87-91; 1987.
7. Sutej, P.G.; Hadler, N.M.: Current Principles of Rehabilitation for Patients with Rheumatoid Arthritis. Clin. Orthop. 265:116-124; 1991.
8. Lehmann, J.F. et al: Therapeutic Heat and Cold. Clin. Orthop. 99:207-245; 1974.
9. Goodwin, J.S.: Mechanisms of Action of Nonsteroidal Anti-inflammatory Agents. Am. J. Med. 77(1A):57-64; 1984.
10. Simons, L.S.; Mills, J.A.: Nonsteroidal Anti-inflammatory Drugs (Part 1). N. Engl. J. Med. 302(21):1179-1185; 1980.
11. Hess, E.V.; Herman, J.H.: Cartilage Metabolism and Anti-inflammatory Drugs in Osteoarthritis. Am. J. Med. 81(Suppl. 5B):36-43; 1986.
12. Palmoski, M.J.; Brandt, K.D.: In Vivo Effect of Aspirin on Canine Osteoarthritic Cartilage. Arthritis Rheum. 26(8):994-1001; 1983.
13. Lipowitz, A.J. et al: Serum Salicylate Concentrations and Endoscopic Evaluation of the Gastric Mucosa in Dogs After Oral Administration of Aspirin-containing Products. AJVR 47(7):1586-1589; 1986.
14. Boulay, J.P. et al: Effect of Cimetidine on Aspirin-induced Gastric Hemorrhage in Dogs. AJVR 47(8):1744-1746; 1986.
15. Murtaugh, R.J. et al: Use of Synthetic Prostaglandin E1 (Misoprostol) for Prevention of Aspirin-induced Gastroduodenal Ulceration in Arthritic Dogs. JAVMA 202:251-256; 1993.
16. Holtzinger, R.H. et al: The Therapeutic Effect of Carprofen (Rimadyl-V) in 209 Clinical Cases of Canine Degenerative Joint Disease. Vet. Comp. Orthop. Traumatol. 5:140-144; 1992.
17. Vasseur, P.B. et al: Evaluation of Carprofen, A Nonsteroidal Anti-inflammatory Drug for Osteoarthritis in Dogs (Abst.). Vet. Surg. 21:409; 1992.
18. McIlwraith, C.W.: Current Concepts in Equine Degenerative Joint Disease. JAVMA 180(2):239-250; 1982.
19. Todhunter, R.J.; Lust, G.: Polysulfated Glycosaminoglycan in the Treatment of Osteoarthritis. JAVMA 204(8):1245-1251; 1994.
20. Glade, M.J.: Polysulfated Glycosaminoglycan Accelerates New Synthesis of Collagen and Glycosaminoglycans by Arthritic Equine Cartilage Tissues and Chondrocytes. AJVR 51:779-785; 1990.
21. Caron, J.D. et al: Influence of Polysulfated Glycosaminoglycan on Equine Cartilage in Explant Culture. AJVR 52:1622-1625; 1991.
22. Cortesque, R. et al: Polysulfated Polysaccharides: An In Vitro Study of Their Effects on Proteoglycan Biosynthesis by Articular Chondrocytes. Arch. Int. Pharmocodyn. Ther. 282:196-208; 1986.
23. Steinmeyer, J. et al: Effects of Three Antiarthritic Drugs on Fibronectin and Keratan Sulfate Synthesis by Cultured Canine Articular Cartilage Chondrocytes. AJVR 25:2077-2083; 1992.
24. Mikulikova, D.; Trnasky, K.: Influence of Glycosaminoglycan Polysulfate (Arteparon) on Lysosomal Enzyme Release from Human Polymorphonuclear Leukocytes. Z. Rheumatol. 41(2):50-53; 1982.
25. Nagase, H.; Woessner J.F. Jr.: Role of Endogenous Proteinases in the Degradation of Cartilage Matrix. Joint Cartilage Degradation: Basic and Clinical Aspects (J.F. Woessner Jr.; D.S. Howell, eds.). Marcel Dekker, New York, N.Y., 1993; pp 159-185.
26. DeHaan, J.J. et al: Evaluation of Polysulfated Glycosaminoglycan for the Treatment of Hip Dysplasia in Dogs. Vet. Surg. 23:177-181 ; 1994.
27. Gustafson, S.B.: Comparison of the Effect of Polysulfated Glycosaminoglycan, Corticosteroids, and Sodium Hyaluronate in the Potentiation of a Subinfective Dose of Staphylococcus aureus in the Midcarpal Joint of Horses. AJVR 40:2014-2017; 1989.
28. Lust, G. et al: Effects of Intramuscular Administration of Glycosaminoglycan Polysulfate on Signs of Incipient Hip Dysplasia in Growing Pups. AJVR 53:1836-1843; 1992.
29. Tulamo, R.M. et al: Concentration and Molecular Weight Distribution of Hyaluronate in Synovial Fluid from Clinically Normal Horses and Horses with Diseased Joints. AJVR 55(5):710-715; 1994.
30. Drovanti, A. et al: Therapeutic Activity of Oral Glucosamine Sulfate in Osteoarthritis: A Placebo-controlled Double-blind Investigation. Clin. Ther. 3(4):260-272; 1980.